A Trial of Cadonilimab Plus Regorafenib in Patients With Hepatocellular Carcinoma Who Failed Camrelizumab Combined With Apatinib

Conditions: Hepatocellular Carcinoma Interventions: Drug: Cadonilimab+regorafenib Sponsors: Meng Chao Hepatobiliary Hospital of Fujian Medical University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials